Cure8 research brief
This study maps myeloid-cell diversity in UC mucosa and proposes two genes (BHLHE40, SERPINA1) as candidate biomarkers—information that could guide future research into diagnostics or targeted therapies.
Researchers of IBD immunology and biomarkers; translational clinicians; scientists using single-cell methods.
This paper used integrated single-cell RNA sequencing and bulk transcriptomic analyses to map myeloid-cell populations in ulcerative colitis (UC) mucosa. The authors report an increased proportion of myeloid cells—particularly MARCO+ macrophages—and identify two genes, BHLHE40 and SERPINA1, as candidate diagnostic biomarkers.
They validated increased expression of mouse orthologs in a DSS-colitis model and performed in silico perturbation to explore possible functions. The study combines publicly available human single-cell and bulk datasets with machine learning, WGCNA, and pathway analyses.
Findings are primarily molecular and exploratory: the work generates hypotheses about myeloid heterogeneity and potential biomarkers rather than reporting clinical diagnostic tests or treatments.
Findings are from integrated transcriptomic analyses and an animal model; the article abstract indicates exploratory molecular findings rather than validated clinical tools.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: National Natural Science Foundation of China, award 82203338; National Natural Science Foundation of China, award 82604958; award 82203338; award 82604958
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study links shared gene-expression patterns between IBD and ankylosing spondylitis and highlights STAT3 as a potential shared biomarker or therapeutic target, which could be relevant for understanding overlapping...
This study proposes three autophagy-related genes (APOL1, CCL2, IL24) as potential biomarkers that may help classify ulcerative colitis patients into subtypes with different immune environments, which could eventually...
The study points to LILRB3 as a tissue biomarker tied to proinflammatory macrophage changes in UC, which could help researchers understand disease mechanisms and guide future biomarker or therapeutic research.
